Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | Open-market sale · 10b5-1 plan | SELL | $18K 64 sh |
| Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | Open-market sale · 10b5-1 plan | SELL | $12K 44 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | Open-market sale · 10b5-1 plan | SELL | $33K 118 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | Open-market sale · 10b5-1 plan | SELL | $17K 60 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Jenkins Robert MExecutive VP and COO | Tax withholding | F | $155K 5,152 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | Open-market sale · 10b5-1 plan | SELL | $36K 129 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | Open-market sale · 10b5-1 plan | SELL | $49K 174 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Ugwumba Chidozie10% Owner | Open-market sale | SELL | $41K 7,923 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 20 | Salisbury Robert WebbExecutive VP and CFO | Tax withholding | F | $99K 3,210 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | Open-market sale · 10b5-1 plan | SELL | $18K 64 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 19 | Weitzel Gregory ThomasCFO | Tax withholding | F | $33K 2,648 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Ways Douglas KirkDirector, Interim Chief Medical Officer | Grant or award | A | — 400 sh | Jan 21, 2026 traded Dec 11, 2025 |
| 19 | Pearce SamanthaEVP, Chief Commercial Officer | Grant or award | A | — 3,637 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Freda FabrizioDirector | Grant or award | A | — 214 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Heeson LeeEVP, Head of Incyte Intl | Grant or award | A | — 8,911 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Mills Desmond JSVP & Chief Accounting Officer | Option exercise | M | — 1,367 sh | Jan 21, 2026 traded Jan 18, 2026 |
| 19 | Ways Douglas KirkDirector, Interim Chief Medical Officer | Disposition to issuer | D | — 400 sh | Jan 21, 2026 traded Dec 11, 2025 |
| 19 | Senn AndrewSVP, Strategy and Business Dev | Option exercise | M | — 630 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 19 | Deneke J HeathChairman, President and CEO | Option exercise | M | — 32.8K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Hazelbaker JillSee Remarks | Option exercise | M | — 2,546 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Ways Douglas KirkDirector, Interim Chief Medical Officer | Disposition to issuer | D | — 266 sh | Jan 21, 2026 traded Dec 11, 2025 |
| 19 | Johnson Margaret LDirector | Grant or award | A | — 214 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Krishnamurthy NikkiSVP and Chief People Officer | Option exercise | M | — 2,001 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Patil Neena MEVP & Chief Legal Officer | Grant or award | A | — 8,852 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Robbins CharlesDirector | Grant or award | A | — 214 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Hoyt CaseyDirector, Chief Executive Officer | Option exercise | M | — 40.1K sh | Jan 21, 2026 traded Jan 17, 2026 |
| 19 | Vestberg Hans ErikDirector | Grant or award | A | — 214 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Harris Kimberley D.Director | Grant or award | A | — 364 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Mault William J.Executive VP and CFO | Option exercise | M | — 10.1K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Ways Douglas KirkDirector, Interim Chief Medical Officer | Option exercise | M | — 1,250 sh | Jan 21, 2026 traded Dec 11, 2025 |
| 19 | Weitzel Gregory ThomasCFO | Disposition to issuer | D | $29K 2,351 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Sicinski Matthew B.Senior VP and CAO | Option exercise | M | — 3,593 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Johnston James DavidExecutive VP, GC, CCO and Secy | Option exercise | M | — 10.8K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Goldstein Robert L.Chief Operating Officer | Grant or award | A | — 4,348 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Deneke J HeathChairman, President and CEO | Option exercise | M | — 32.8K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Weitzel Gregory ThomasCFO | Grant or award | A | — 2,351 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Weitzel Gregory ThomasCFO | Tax withholding | F | $35K 2,798 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Peck Kristin CDirector | Grant or award | A | — 214 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Morrissey Michael JamesEVP, Head of Tech. Operations | Grant or award | A | — 7,426 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 19 | Wilson Mark ADirector | Grant or award | A | — 214 sh | Jan 21, 2026 traded Jan 16, 2026 |